Literature DB >> 27339071

Slowly eroding lesions in multiple sclerosis.

Varun Sethi1, Govind Nair1, Martina Absinta1, Pascal Sati1, Arun Venkataraman1, Joan Ohayon1, Tianxia Wu1, Kelly Yang1, Colin Shea1, Blake E Dewey1, Irene Cm Cortese1, Daniel S Reich1.   

Abstract

BACKGROUND: At autopsy, 20%-40% of chronic multiple sclerosis (MS) lesions are labeled "slowly expanding" and feature myelin phagocytosis at the lesion edge. As pathological lesion classification relies on a single, terminal time point, the rate of lesion expansion cannot be directly measured.
OBJECTIVE: To study long-term volume changes in individual MS lesions.
METHODS: Volumes of individual lesions on proton density magnetic resonance imaging (MRI) acquired between 1992 and 2015 were measured in 22 individuals (one lesion per person). After correction for acquisition protocol, a mixed model evaluated lesion volume changes.
RESULTS: The mean (standard deviation) lesion volume at baseline was 142 (82) mL, falling to 74 (51) mL after 16 (3) years. All lesions shrank over time. Change in lesion volume did not correlate with change in supratentorial brain volume ( p = 0.33). In simulations, the results could be explained by a process of slow radial expansion superimposed on substantially more rapid resorption of damaged tissue.
CONCLUSION: We noted sustained radiological contraction of MS lesions, a surprising result given that fresh myelin breakdown products within chronic active lesions are observed relatively frequently at autopsy. Therefore, the primary pathological process in chronic lesions, even those described as "slowly expanding," is likely to be tissue loss.

Entities:  

Keywords:  Slowly expanding lesion; magnetic resonance imaging; multiple sclerosis; proton density

Mesh:

Year:  2016        PMID: 27339071      PMCID: PMC5182188          DOI: 10.1177/1352458516655403

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  34 in total

1.  Immunopathology of secondary-progressive multiple sclerosis.

Authors:  J W Prineas; E E Kwon; E S Cho; L R Sharer; M H Barnett; E L Oleszak; B Hoffman; B P Morgan
Journal:  Ann Neurol       Date:  2001-11       Impact factor: 10.422

2.  Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis.

Authors:  N D Richert; J L Ostuni; C N Bash; T P Leist; H F McFarland; J A Frank
Journal:  Mult Scler       Date:  2001-02       Impact factor: 6.312

3.  Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types.

Authors:  H Vrenken; A Seewann; D L Knol; C H Polman; F Barkhof; J J G Geurts
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-22       Impact factor: 3.825

Review 4.  Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis.

Authors:  M Filippi; M A Horsfield; P S Tofts; F Barkhof; A J Thompson; D H Miller
Journal:  Brain       Date:  1995-12       Impact factor: 13.501

Review 5.  Oligodendrocytes and the early multiple sclerosis lesion.

Authors:  John W Prineas; John D E Parratt
Journal:  Ann Neurol       Date:  2012-07       Impact factor: 10.422

6.  Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD.

Authors:  Gabriela Spulber; Eini Niskanen; Stuart Macdonald; Miia Kivipelto; Daniel Ferreira Padilla; Valtteri Julkunen; Merja Hallikainen; Ritva Vanninen; Lars-Olof Wahlund; Hilkka Soininen
Journal:  Curr Alzheimer Res       Date:  2012-05       Impact factor: 3.498

7.  Comparison of MR pulse sequences in the detection of multiple sclerosis lesions.

Authors:  T A Yousry; M Filippi; C Becker; M A Horsfield; R Voltz
Journal:  AJNR Am J Neuroradiol       Date:  1997-05       Impact factor: 3.825

8.  Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.

Authors:  Alexandra Seewann; Hugo Vrenken; Paul van der Valk; Erwin L A Blezer; Dirk L Knol; Jonas A Castelijns; C H Polman; Petra J W Pouwels; Frederik Barkhof; Jeroen J G Geurts
Journal:  Arch Neurol       Date:  2009-05

9.  Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR.

Authors:  Olga Ciccarelli; Peter A Brex; Alan J Thompson; David H Miller
Journal:  J Neurol       Date:  2002-01       Impact factor: 4.849

10.  Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.

Authors:  Florian Then Bergh; Tania Kümpfel; Erina Schumann; Ulrike Held; Michaela Schwan; Mirjana Blazevic; Axel Wismüller; Florian Holsboer; Alexander Yassouridis; Manfred Uhr; Frank Weber; Martin Daumer; Claudia Trenkwalder; Dorothee P Auer
Journal:  BMC Neurol       Date:  2006-05-23       Impact factor: 2.474

View more
  15 in total

Review 1.  Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting.

Authors:  Carmen Tur; Marcello Moccia; Frederik Barkhof; Jeremy Chataway; Jaume Sastre-Garriga; Alan J Thompson; Olga Ciccarelli
Journal:  Nat Rev Neurol       Date:  2018-01-12       Impact factor: 42.937

2.  Smoldering lesions in MS: if you like it then you should put a rim on it.

Authors:  Catarina Pinto; Melissa Cambron; Adrienn Dobai; Eva Vanheule; Jan W Casselman
Journal:  Neuroradiology       Date:  2021-09-09       Impact factor: 2.804

Review 3.  Recent advances in the longitudinal segmentation of multiple sclerosis lesions on magnetic resonance imaging: a review.

Authors:  Marcos Diaz-Hurtado; Eloy Martínez-Heras; Elisabeth Solana; Jordi Casas-Roma; Sara Llufriu; Baris Kanber; Ferran Prados
Journal:  Neuroradiology       Date:  2022-07-22       Impact factor: 2.995

4.  Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions.

Authors:  C Elliott; D L Arnold; H Chen; C Ke; L Zhu; I Chang; E Cahir-McFarland; E Fisher; B Zhu; S Gheuens; M Scaramozza; V Beynon; N Franchimont; D P Bradley; S Belachew
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-20       Impact factor: 3.825

5.  Profiles of cortical inflammation in multiple sclerosis by 11C-PBR28 MR-PET and 7 Tesla imaging.

Authors:  Elena Herranz; Céline Louapre; Constantina Andrada Treaba; Sindhuja T Govindarajan; Russell Ouellette; Gabriel Mangeat; Marco L Loggia; Julien Cohen-Adad; Eric C Klawiter; Jacob A Sloane; Caterina Mainero
Journal:  Mult Scler       Date:  2019-08-01       Impact factor: 5.855

Review 6.  Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.

Authors:  Massimo Filippi; Paolo Preziosa; Brenda L Banwell; Frederik Barkhof; Olga Ciccarelli; Nicola De Stefano; Jeroen J G Geurts; Friedemann Paul; Daniel S Reich; Ahmed T Toosy; Anthony Traboulsee; Mike P Wattjes; Tarek A Yousry; Achim Gass; Catherine Lubetzki; Brian G Weinshenker; Maria A Rocca
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

Review 7.  Advances in brain imaging in multiple sclerosis.

Authors:  Rosa Cortese; Sara Collorone; Olga Ciccarelli; Ahmed T Toosy
Journal:  Ther Adv Neurol Disord       Date:  2019-06-27       Impact factor: 6.570

8.  A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.

Authors:  Erik Nutma; Jodie A Stephenson; Rianne P Gorter; Joy de Bruin; Deirdre M Boucherie; Cornelius K Donat; Marjolein Breur; Paul van der Valk; Paul M Matthews; David R Owen; Sandra Amor
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

9.  Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.

Authors:  Colm Elliott; Jerry S Wolinsky; Stephen L Hauser; Ludwig Kappos; Frederik Barkhof; Corrado Bernasconi; Wei Wei; Shibeshih Belachew; Douglas L Arnold
Journal:  Mult Scler       Date:  2018-12-19       Impact factor: 6.312

10.  Gray matter blood-brain barrier water exchange dynamics are reduced in progressive multiple sclerosis.

Authors:  Ian J Tagge; Valerie C Anderson; Charles S Springer; Manoj K Sammi; Dennis N Bourdette; Rebecca I Spain; William D Rooney
Journal:  J Neuroimaging       Date:  2021-08-06       Impact factor: 2.324

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.